Spinogenix Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Series D
- Latest Deal Amount
-
$10.6M
- Investors
-
4
Spinogenix General Information
Description
Operator of a biopharmaceutical company intended to restore the brain connections and functions lost in brain injury and neurodegenerative diseases. The company offers drugs to reverse synapse loss, restoring connections lost to neurodegenerative diseases and other conditions involving the central nervous system, enabling patients to regenerate synapses through their direct modulation of synaptic proteins.
Contact Information
Website
www.spinogenix.comCorporate Office
- 1801 Century Park East
- Suite 2400
- Los Angeles, CA 90067
- United States
Corporate Office
- 1801 Century Park East
- Suite 2400
- Los Angeles, CA 90067
- United States
Spinogenix Timeline
Spinogenix Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC (Series D) | 09-Mar-2026 | $10.6M | Completed | Clinical Trials - Phase 2 | ||
| 8. Later Stage VC (Series C) | 07-Jun-2024 | Completed | Clinical Trials - Phase 1 | |||
| 7. Later Stage VC (Series B) | 21-Jun-2024 | Completed | Clinical Trials - Phase 1 | |||
| 6. Grant | 26-Sep-2023 | Completed | Startup | |||
| 5. Later Stage VC (Series A3) | 10-Sep-2022 | Completed | Pre-Clinical Trials | |||
| 4. Later Stage VC (Series A) | 23-Feb-2021 | Completed | Pre-Clinical Trials | |||
| 3. Seed Round | 03-May-2018 | Completed | Pre-Clinical Trials | |||
| 2. Grant | 01-Jan-2018 | $315K | Completed | Pre-Clinical Trials | ||
| 1. University Spin-Out | 01-Jan-2016 | Completed | Startup |
Spinogenix Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D-1 | ||||||||
| Series D | ||||||||
| Series C | ||||||||
| Series B | ||||||||
| Series A-3 | ||||||||
| Series A-2 | ||||||||
| Series A-1 | 116,619 | $0.000100 | 8% | $2.25 | $2.25 | 1x | $2.25 | 1.22% |
| Seed | 979,163 | $0.000100 | 8% | $1 | $1 | 1x | $1 | 10.21% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Spinogenix Patents
Spinogenix Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026050308-A1 | Benzothiazole compound for treating or preventing diabetes | Pending | 26-Aug-2024 | ||
| WO-2026050303-A1 | Methods of treating ophthalmic diseases | Pending | 26-Aug-2024 | ||
| AU-2025228499-A1 | Methods for prevention and treatment of depression | Pending | 29-Feb-2024 | ||
| WO-2025184576-A1 | Methods for prevention and treatment of depression | Pending | 29-Feb-2024 | ||
| AU-2024244089-A1 | Methods of dosing spinogenic compounds | Pending | 03-Apr-2023 | A61K31/428 |
Spinogenix Signals
Spinogenix Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Stead Impact Ventures and Foundation | Impact Investing | Minority | ||
| United States Department of War | Government | |||
| U.S. Department of Health and Human Services | Government | |||
| University of California, San Diego | University | Minority |
Spinogenix FAQs
-
When was Spinogenix founded?
Spinogenix was founded in 2016.
-
Where is Spinogenix headquartered?
Spinogenix is headquartered in Los Angeles, CA.
-
What is the size of Spinogenix?
Spinogenix has 5 total employees.
-
What industry is Spinogenix in?
Spinogenix’s primary industry is Drug Discovery.
-
Is Spinogenix a private or public company?
Spinogenix is a Private company.
-
What is the current valuation of Spinogenix?
The current valuation of Spinogenix is .
-
What is Spinogenix’s current revenue?
The current revenue for Spinogenix is .
-
How much funding has Spinogenix raised over time?
Spinogenix has raised $27.5M.
-
Who are Spinogenix’s investors?
Stead Impact Ventures and Foundation, United States Department of War, U.S. Department of Health and Human Services, and University of California, San Diego have invested in Spinogenix.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process